PECORARI, SILVIA
 Distribuzione geografica
Continente #
NA - Nord America 355
EU - Europa 58
AS - Asia 40
AF - Africa 1
Totale 454
Nazione #
US - Stati Uniti d'America 353
IT - Italia 30
SG - Singapore 20
SE - Svezia 14
CN - Cina 11
IN - India 9
DE - Germania 4
FI - Finlandia 3
CA - Canada 2
IE - Irlanda 2
RO - Romania 2
BG - Bulgaria 1
CH - Svizzera 1
RS - Serbia 1
TG - Togo 1
Totale 454
Città #
Fairfield 74
Seattle 39
Ashburn 31
Chandler 31
Woodbridge 30
Cambridge 28
Houston 18
Singapore 15
Wilmington 13
Rome 11
Beijing 8
Ann Arbor 7
Plano 5
Princeton 5
San Diego 4
Fremont 3
Helsinki 3
Lawrence 3
Marcallo con Casone 3
Andover 2
Boardman 2
Boston 2
Dearborn 2
Dublin 2
New York 2
Phoenix 2
San Paolo di Civitate 2
Santa Clara 2
Basel 1
Bremen 1
Castelraimondo 1
Columbus 1
Des Moines 1
Falls Church 1
Genova 1
Grafing 1
Guangzhou 1
Hefei 1
Jinan 1
Lomé 1
Los Angeles 1
Milan 1
Millbury 1
Ottawa 1
Sofia 1
Toronto 1
Totale 367
Nome #
A simplified genomic profiling approach predicts outcome in metastatic colorectal cancer 142
M8Concomitant versus sequential Fotemustine and Bevacizumab in recurrent malignant gliomas: treatment response and survival outcomes in a retrospective analysis 84
Multimodal treatment for local recurrent malignant gliomas: resurgery and/or reirradiation followed by chemotherapy 81
Therapeutic approach in glioblastoma multiforme with primitive neuroectodermal tumor components: case report and review of the literature 69
null 47
null 33
Evaluation of the efficacy of cisplatin–etoposide and the role of thoracic radiotherapy and prophylactic cranial irradiation in LCNEC 14
Retrospective analysis to evaluate the efficacy and the safety of Bevacizumab in the treatment of recurrent malignant gliomas 12
Totale 482
Categoria #
all - tutte 1.140
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 1.140


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020129 0 3 3 9 17 15 22 18 14 13 7 8
2020/202169 4 5 1 2 0 28 6 3 6 9 4 1
2021/202258 0 2 4 3 7 2 1 6 1 3 18 11
2022/202374 9 10 3 11 9 5 2 13 12 0 0 0
2023/202439 4 5 5 2 6 4 0 2 0 2 2 7
2024/202514 1 13 0 0 0 0 0 0 0 0 0 0
Totale 482